This paper is in the following e-collection/theme issue:

Infoveillance, Infodemiology, Digital Disease Surveillance, Infodemic Management (1050) Medicine 2.0: Social Media, Open, Participatory, Collaborative Medicine (1666) Infodemiology and Infoveillance (1369) Pharmacovigilance (138) Infoveillance and Social Listening (214)

Published on in Vol 3, No 1 (2017): Jan-Mar

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis

Authors of this article:

Laurie S. Anderson1 Author Orcid Image ;   Heidi G Bell2 Author Orcid Image ;   Michael Gilbert3 Author Orcid Image ;   Julie E Davidson4 Author Orcid Image ;   Christina Winter4 Author Orcid Image ;   Monica J Barratt5, 6, 7 Author Orcid Image ;   Beta Win4 Author Orcid Image ;   Jeffery L Painter1 Author Orcid Image ;   Christopher Menone3 Author Orcid Image ;   Jonathan Sayegh7 Author Orcid Image ;   Nabarun Dasgupta3 Author Orcid Image
Article Authors Cited by (37) Tweetations (13) Metrics

Laurie S. Anderson   1 * , PharmD ;   Heidi G Bell   2 * , RPh, MD ;   Michael Gilbert   3 , MPH ;   Julie E Davidson   4 , MPH, PhD ;   Christina Winter   4 , MD ;   Monica J Barratt   5, 6, 7 , PhD ;   Beta Win   4 , MSc ;   Jeffery L Painter   1 , JD ;   Christopher Menone   3 , MESc ;   Jonathan Sayegh   7 , JD ;   Nabarun Dasgupta   3 , MPH, PhD

1 GlaxoSmithKline, Research Triangle Park, NC, United States

2 Gyra MediPharm Consulting, Research Triangle Park, NC, United States

3 Epidemico, Inc, Boston, MA, United States

4 GlaxoSmithKline, Stockley Park, Middlesex, United Kingdom

5 National Drug and Alcohol Research Centre, UNSW Australia, Randwick, Australia

6 Bluelight.org, Dover, DE, United States

7 Kadiant Analytics, Boston, MA, United States

*these authors contributed equally

Corresponding Author:

  • Laurie S. Anderson, PharmD
  • GlaxoSmithKline
  • 5 Moore Drive
  • PO Box 13398
  • Research Triangle Park, NC, 27709-3398
  • United States
  • Phone: 1 919 475 0747
  • Fax: 1 000-000-0000
  • Email: laurie.s.anderson@gsk.com